Td Asset Management Inc Relay Therapeutics, Inc. Transaction History

Td Asset Management Inc

$102 Billion
Q1 2025

A detailed history of Td Asset Management Inc transactions in Relay Therapeutics, Inc. stock. As of the latest transaction made, Td Asset Management Inc holds 156,456 shares of RLAY stock, worth $506,917. This represents 0.0% of its overall portfolio holdings.

Number of Shares

156,456

Previous 156,456 -0.0%

Holding current value

$506,917

Previous $644,000 36.49%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 11, 2025	SELL	$4.12 - $6.8 $124,424 - $205,360	-30,200 Reduced 16.18%	156,456 $644,000
Q3 2024 Nov 01, 2024	SELL	$6.23 - $9.51 $120,862 - $184,494	-19,400 Reduced 9.41%	186,656 $1.32 Million
Q2 2024 Aug 02, 2024	SELL	$5.9 - $8.02 $900,340 - $1.22 Million	-152,600 Reduced 42.55%	206,056 $1.34 Million
Q1 2024 May 08, 2024	SELL	$7.5 - $12.07 $819,825 - $1.32 Million	-109,310 Reduced 23.36%	358,656 $2.98 Million
Q4 2023 Feb 12, 2024	SELL	$6.01 - $11.48 $177,439 - $338,935	-29,524 Reduced 5.93%	467,966 $5.15 Million
Q3 2023 Oct 27, 2023	BUY	$8.24 - $12.97 $1.93 Million - $3.03 Million	233,983 Added 88.8%	497,490 $4.18 Million
Q2 2023 Aug 09, 2023	BUY	$9.99 - $18.27 $466,433 - $853,026	46,690 Added 21.53%	263,507 $3.31 Million
Q1 2023 May 10, 2023	BUY	$15.0 - $22.76 $1.4 Million - $2.12 Million	93,255 Added 75.47%	216,817 $3.57 Million
Q4 2022 Feb 06, 2023	BUY	$14.16 - $24.02 $59,472 - $100,884	4,200 Added 3.52%	123,562 $1.85 Million
Q3 2022 Nov 07, 2022	BUY	$18.07 - $31.37 $349,925 - $607,480	19,365 Added 19.37%	119,362 $2.76 Million
Q1 2022 May 10, 2022	BUY	$20.26 - $32.36 $18,193 - $29,059	898 Added 0.91%	99,997 $2.99 Million
Q4 2021 Feb 10, 2022	BUY	$26.0 - $37.03 $1.87 Million - $2.67 Million	72,092 Added 266.94%	99,099 $3.04 Million
Q3 2021 Nov 09, 2021	BUY	$29.75 - $37.99 $142,800 - $182,352	4,800 Added 21.61%	27,007 $852,000
Q1 2021 May 14, 2021	BUY	$32.52 - $61.53 $125,754 - $237,936	3,867 Added 21.09%	22,207 $768,000
Q3 2020 Nov 10, 2020	BUY	$32.81 - $45.1 $601,735 - $827,134	18,340 New	18,340 $781,000

Others Institutions Holding RLAY

# of Institutions

220

Shares Held

163M

Call Options Held

153K

Put Options Held

49.2K

View Full List

About Relay Therapeutics, Inc.

Ticker RLAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 120,219,000
Market Cap $390M
Description
Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...

More about RLAY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Td Asset Management Inc with notifications on news.

Account

Td Asset Management Inc Relay Therapeutics, Inc. Transaction History